AP521A - Piperidinyl compounds - Google Patents

Piperidinyl compounds Download PDF

Info

Publication number
AP521A
AP521A APAP/P/1994/000652A AP9400652A AP521A AP 521 A AP521 A AP 521A AP 9400652 A AP9400652 A AP 9400652A AP 521 A AP521 A AP 521A
Authority
AP
ARIPO
Prior art keywords
formula
compound
alkyl
piperidin
dihydro
Prior art date
Application number
APAP/P/1994/000652A
Other languages
English (en)
Other versions
AP9400652A0 (en
Inventor
Michael Thaddeus Klimas
Marc Ornal Terpko
Original Assignee
Zeneca Ltd And Zeneca Pharma S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd And Zeneca Pharma S A filed Critical Zeneca Ltd And Zeneca Pharma S A
Publication of AP9400652A0 publication Critical patent/AP9400652A0/xx
Application granted granted Critical
Publication of AP521A publication Critical patent/AP521A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
APAP/P/1994/000652A 1993-07-09 1994-06-30 Piperidinyl compounds AP521A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314250A GB9314250D0 (en) 1993-07-09 1993-07-09 Piperidinyl compounds

Publications (2)

Publication Number Publication Date
AP9400652A0 AP9400652A0 (en) 1994-07-31
AP521A true AP521A (en) 1996-08-05

Family

ID=10738563

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000652A AP521A (en) 1993-07-09 1994-06-30 Piperidinyl compounds

Country Status (26)

Country Link
EP (1) EP0707579B1 (fr)
JP (1) JP3031634B2 (fr)
AP (1) AP521A (fr)
AT (1) ATE175963T1 (fr)
AU (1) AU687414B2 (fr)
CA (1) CA2163994A1 (fr)
CZ (1) CZ4496A3 (fr)
DE (1) DE69416131T2 (fr)
DK (1) DK0707579T3 (fr)
DZ (1) DZ1796A1 (fr)
ES (1) ES2128567T3 (fr)
FI (1) FI960084A0 (fr)
GB (2) GB9314250D0 (fr)
HR (1) HRP940394A2 (fr)
HU (1) HU219239B (fr)
IL (1) IL110222A (fr)
MY (1) MY111604A (fr)
NO (1) NO960080L (fr)
NZ (1) NZ268048A (fr)
PL (1) PL312498A1 (fr)
RU (1) RU2128178C1 (fr)
SG (1) SG45425A1 (fr)
SI (1) SI9400281A (fr)
SK (1) SK2996A3 (fr)
WO (1) WO1995001974A1 (fr)
ZA (1) ZA944930B (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533344A1 (fr) * 1991-08-15 1993-03-24 Zeneca Limited Méthanoanthracènes comme antagonistes de dopamine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533344A1 (fr) * 1991-08-15 1993-03-24 Zeneca Limited Méthanoanthracènes comme antagonistes de dopamine

Also Published As

Publication number Publication date
EP0707579B1 (fr) 1999-01-20
SG45425A1 (en) 1998-01-16
ES2128567T3 (es) 1999-05-16
ZA944930B (en) 1995-01-16
MY111604A (en) 2000-09-27
JP3031634B2 (ja) 2000-04-10
SI9400281A (en) 1995-02-28
DE69416131T2 (de) 1999-06-10
JPH08512308A (ja) 1996-12-24
NZ268048A (en) 1997-10-24
GB9413235D0 (en) 1994-08-24
ATE175963T1 (de) 1999-02-15
HU219239B (en) 2001-03-28
FI960084A7 (fi) 1996-01-08
HRP940394A2 (en) 1996-12-31
WO1995001974A1 (fr) 1995-01-19
SK2996A3 (en) 1997-02-05
RU2128178C1 (ru) 1999-03-27
IL110222A0 (en) 1994-10-21
NO960080D0 (no) 1996-01-08
PL312498A1 (en) 1996-04-29
EP0707579A1 (fr) 1996-04-24
HU9503554D0 (en) 1996-02-28
AU7077994A (en) 1995-02-06
DE69416131D1 (de) 1999-03-04
AU687414B2 (en) 1998-02-26
DK0707579T3 (da) 1999-09-13
DZ1796A1 (fr) 2002-02-17
GB9314250D0 (en) 1993-08-18
FI960084A0 (fi) 1996-01-08
CZ4496A3 (en) 1996-06-12
HUT75116A (en) 1997-04-28
NO960080L (no) 1996-01-08
AP9400652A0 (en) 1994-07-31
CA2163994A1 (fr) 1995-01-19
IL110222A (en) 1999-09-22

Similar Documents

Publication Publication Date Title
KR100360633B1 (ko) Nos 억제제로서 유용한 6-페닐피리딜-2-아민 유도체
EP0533344B1 (fr) Méthanoanthracènes comme antagonistes de dopamine
FR2563521A1 (fr) Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents antibacteriens les contenant
AU681601B2 (en) O-aryl ethers of morphinans
JPWO2009041559A1 (ja) インダゾールアクリル酸アミド化合物
US5681840A (en) Tricyclic antipsychotic compounds
CZ94098A3 (cs) Tertahydrochinolinové deriváty, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
KR20190057388A (ko) Ror 감마 조정제로서의 트리시클릭 술폰
JPH05117268A (ja) ピリジン化合物
JP2003509494A (ja) ムスカリン拮抗薬
KR20160003244A (ko) 퀴놀론 유도체
AU687414B2 (en) Piperidinyl substituted methanoanthracenes as D1/D2-antagonists and 5HT2-serotanin-antagonists
TW202229251A (zh) 乙醯胺基-苯基苯甲醯胺衍生物及其使用方法
JP2010229096A (ja) 医薬組成物